Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Christian S. Breburda is active.

Publication


Featured researches published by Christian S. Breburda.


Journal of the American College of Cardiology | 1998

Three-dimensional echocardiographic planimetry of maximal regurgitant orifice area in myxomatous mitral regurgitation: intraoperative comparison with proximal flow convergence

Christian S. Breburda; Brian P. Griffin; Min Pu; L. Leonardo Rodriguez; Delos M. Cosgrove; James D. Thomas

OBJECTIVES We sought to validate direct planimetry of mitral regurgitant orifice area from three-dimensional echocardiographic reconstructions. BACKGROUND Regurgitant orifice area (ROA) is an important measure of the severity of mitral regurgitation (MR) that up to now has been calculated from hemodynamic data rather than measured directly. We hypothesized that improved spatial resolution of the mitral valve (MV) with three-dimensional (3D) echo might allow accurate planimetry of ROA. METHODS We reconstructed the MV using 3D echo with 3 degrees rotational acquisitions (TomTec) using a transesophageal (TEE) multiplane probe in 15 patients undergoing MV repair (age 59 +/- 11 years). One observer reconstructed the prolapsing mitral leaflet in a left atrial plane parallel to the ROA and planimetered the two-dimensional (2D) projection of the maximal ROA. A second observer, blinded to the results of the first, calculated maximal ROA using the proximal convergence method defined as maximal flow rate (2pi(r2)va, where r is the radius of a color alias contour with velocity va) divided by regurgitant peak velocity (obtained by continuous wave [CW] Doppler) and corrected as necessary for proximal flow constraint. RESULTS Maximal ROA was 0.79 +/- 0.39 (mean +/- SD) cm2 by 3D and 0.86 +/- 0.42 cm2 by proximal convergence (p = NS). Maximal ROA by 3D echo (y) was highly correlated with the corresponding flow measurement (x) (y = 0.87x + 0.03, r = 0.95, p < 0.001) with close agreement seen (AROA (y - x) = 0.07 +/- 0.12 cm2). CONCLUSIONS 3D echo imaging of the MV allows direct visualization and planimetry of the ROA in patients with severe MR with good agreement to flow-based proximal convergence measurements.


Journal of The American Society of Echocardiography | 1998

Left ventricular ejection fraction in patients with normal and distorted left ventricular shape by three-dimensional echocardiographic methods: A comparison with radionuclide angiography

Youssef F.M. Nosir; Alessandro Salustri; Jarosław D. Kasprzak; Christian S. Breburda; Folkert J. ten Cate; Jos R.T.C. Roelandt

BACKGROUND Serial evaluation of left ventricular (LV) ejection fraction (EF) is important for the management and follow-up of cardiac patients. Our aim was to compare LVEF calculated from two three-dimensional echocardiographic (3DE) methods with multigated radionuclide angiography (RNA), in patients with normal and abnormally shaped ventricles. METHODS AND RESULTS Forty-one consecutive patients referred for RNA underwent precordial rotational 3DE acquisition of 90 cut-planes. From the volumetric data set, LVEF was calculated by (a) Simpsons rule (3DS) through manual endocardial tracing of LV short-axis series at 3 mm slice distance and (b) apical biplane modified Simpsons method ( MS) in 29 patients by manual endocardial tracing of the apical four-chamber view and its computer-derived orthogonal view. Patients included three groups: A, 17 patients with LV segmental wall motion abnormalities; B, 13 patients with LV global hypokinesis; and C, 11 patients with normal LV wall motion. For all the 41 patients, there was excellent correlation, close limits of agreement, and nonsignificant difference between 3DS and RNA for LVEF calculation (r = 0.99, [-6.7, +6.9] and p = 0.9), respectively. For the 29 patients, excellent correlation and nonsignificant differences between LVEF calculated by both 3DS and BMS and values obtained by RNA were found (r = 0.99 and 0.97, p = 0.7 and p = 0.5, respectively). In addition, no significant difference existed between values of LVEF obtained from RNA, 3DS, and BMS by the analysis of variance (p = 0.6). The limits of agreement tended to be closer between 3DS and RNA (-6.8, +7.2) than between BMS and RNA (-8.3, +9.7). The intraobserver and inter-observer variability of RNA, 3DS, and BMS for calculating LVEF(%) were (0.8, 1.5), (1.3, 1.8), and (1.6, 2.6), respectively. There were closer limits of agreement between 3DS and RNA for LVEF calculation in A, B, and C patient subgroups [(-3.5, +5), (-8.4, +5.6), and (-7.8, +8.6)] than that between BMS and RNA [(-8.1, +10.7), (-11.9, +9.3), and (-9.1, +11.3)], respectively. CONCLUSIONS No significant difference existed between RNA, 3DS, and BMS for LVEF calculation. 3DS has better correlation and closer limits of agreement than BMS with RNA for LVEF calculation, particularly in patients with segmental wall motion abnormalities and global hypokinesis. 3DS has a comparable observer variability with RNA. Therefore the use of 3DS for serial accurate LVEF calculation in cardiac patients is recommended.


Journal of The American Society of Echocardiography | 2008

Three-Dimensional Echocardiographic Assessment of a Serpiginous Ventricular Septal Defect

Ankur Bant; Christopher Dominguez; Ellen Glazier; Mehrdad Saririan; Jay Kaufman; Christian S. Breburda

Ventricular septal defects are one of the most common congenital heart defects that either exist alone or coexist with other complex congenital heart diseases. With 3-dimensional echocardiography, exact 3-dimensional shape, size, location, and course of any ventricular septal defects can be evaluated very thoroughly. We are reporting a comprehensive assessment of a complex ventricular septal defect using 3-dimensional echocardiography and longitudinal strain analysis.


Journal of The American Society of Echocardiography | 2003

Intraoperative assessment of coronary grafts by novel digital epivascular imaging

Christian S. Breburda; Heinz Koester; Rainer Moosdorf

OBJECTIVE We sought to validate and evaluate 2 novel intraoperative ultrasound probes for epicoronary and epiaortic imaging. BACKGROUND The noninvasive intraoperative assessment of successful coronary artery bypass grafting remains a challenge. METHODS A total of 19 consecutive patients (4 female, 15 male; mean age 60.5 +/- 13.8 years SD, range 34-84) underwent coronary artery bypass grafting. The epivascular probes (GE Ultrasound) were validated in vitro and intraoperatively. Coronary arteries, grafts, and ascending aorta were imaged and quantified. RESULTS Mean adjusted flow measured by flowmeter was 3.25 L, SE 0.47 (range: 1-5.5 L) and was 3.15 L, SE 0.46 (range: 1-5.0 L) by ultrasound, with r = 0.97, P <.0001. Intraoperatively, 56 native coronary vessels were bypassed using 15 left internal mammary artery grafts, 25 vein grafts, and 16 venous jump grafts. A total of 15 left internal mammary artery grafts (100%), 12 left internal mammary artery anastomoses (80%), 20 vein grafts (15 left anterior descending coronary arteries, left circumflex artery grafts, 5 right coronary artery grafts) (80%), 4 jump grafts (25%), and 15 ascending aortas (78%) were successfully imaged by inexperienced surgeons. Doppler flow measurements were possible in 50 vessels (89%). Mean lumen diameter for graft arteries (veins) was 2 mm (2.87 mm), maximal velocity was 72 cm/s (46 cm/s), and mean velocity was 29 cm/s (21 cm/s) with a mean flow rate of 70 mL/m (55 mL/m). CONCLUSIONS We conclude that: (1) the novel intraoperative probes measure validated flow; (2) intraoperative hemodynamic assessment of graft patency is feasible without a learning curve; and (3) these findings should encourage the routine use of these intraoperative epivascular digital ultrasound probes.


Circulation (Baltimore) | 2000

Images in Cardiovascular Medicine

Christian S. Breburda; Robert-Jan van Geuns; Jos A. Bekkers; Maarten Janssen; Jos R.T.C. Roelandt; Peter Klootwijk; Walter R.M. Hermans


European Heart Journal | 1998

Safety and utility of atropine addition during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction

Don Poldermans; Ricardo Rambaldi; Jeroen J. Bax; Jan H. Cornel; Ian R. Thomson; Roelf Valkema; Eric Boersma; Paolo M. Fioretti; Christian S. Breburda; Jos R.T.C. Roelandt


Archive | 2002

Method and apparatus for cardiac elastography

Tomy Varghese; Christian S. Breburda; James A. Zagzebski; Peter S. Rahko


Archive | 2003

Apparatus for cardiac elastography

Tomy Varghese; Christian S. Breburda; James A. Zagzebski; Peter S. Rahko


/data/revues/08947317/v8i3/S089473170580094X/ | 2011

Aortic valve morphology predicts progression of valve dysfunction in bicuspid aortic valve: Echo-Doppler follow-up of 52 patients

Brian M. McClements; Dan Gilon; Michael J.A. Williams; Christian S. Breburda; Mary Etta King; Michael H. Picard; Robert A. Levine


Journal of the American College of Cardiology | 2004

1030-136 Echocardiographic presence of mitral annular calcification predicts increased mortality in patients with normal left ventricular ejection fraction

Gustavo A. Cardenas; Mark X Jiang; Nirankar V Metha; Richard V. Milani; Christian S. Breburda

Collaboration


Dive into the Christian S. Breburda's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

James A. Zagzebski

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar

Peter S. Rahko

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar

Tomy Varghese

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jos R.T.C. Roelandt

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge